Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NGM Biopharmaceuticals Inc (was acquired by Atlas Neon Parent, Inc. on 05/04/2024) (NGM)

  • Event
  • July 13, 2022, 20:07 UTC
  • 11
  • 1 comments

(99% Neutral) NGM BIOPHARMACEUTICALS INC (NGM) Announces Business Combination

Comment Full text

Sanofi (SNY)

  • Event
  • July 13, 2022, 17:40 UTC
  • 8
  • 1 comments

(90% Positive) Sanofi (SNY) Announces Clinical Development Update (Form 6-K)

Comment Full text

Gossamer Bio Inc (GOSS)

  • Event
  • July 13, 2022, 12:45 UTC
  • 11
  • 1 comments

(99% Neutral) GOSSAMER BIO, INC. (GOSS) Announces Business Combination

Comment Full text

Legend Biotech (LEGN)

  • Event
  • July 13, 2022, 12:30 UTC
  • 8
  • 1 comments

(99% Neutral) Legend Biotech (LEGN) Files Form 6-K

Comment Full text

Alaunos Therapeutics Inc (TCRT)

  • Event
  • July 13, 2022, 12:00 UTC
  • 11
  • 1 comments

(99% Neutral) Alaunos Therapeutics, Inc. (TCRT) Announces Update on Collaboration with Registrant

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • July 13, 2022, 11:19 UTC
  • 10
  • 1 comments

(90% Positive) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K)

Comment Full text

Revolution Medicines Inc (RVMD)

  • Event
  • July 13, 2022, 11:05 UTC
  • 11
  • 1 comments

(99% Neutral) REVOLUTION MEDICINES, INC. (RVMD) Announces New Board Appointment

Comment Full text

OptiNose Inc (OPTN)

  • Event
  • July 13, 2022, 11:00 UTC
  • 11
  • 1 comments

(70% Positive) OPTINOSE, INC. (OPTN) Provides Update on visits for 70% of visits

Comment Full text

Bioventus Inc (BVS)

  • Event
  • July 12, 2022, 20:53 UTC
  • 11
  • 1 comments

(99% Neutral) Bioventus Inc. (BVS) Announces Business Combination

Comment Full text

Oyster Point Pharma Inc (the company became a subdivision of the company Viatris Inc. (Nasdaq: VTRS) (OYST)

  • Event
  • July 12, 2022, 20:45 UTC
  • 11
  • 1 comments

(99% Neutral) Oyster Point Pharma, Inc. (OYST) Announces Executive Changes

Comment Full text
  • Previous
  • 160
  • 161
  • 162
  • 163
  • 164
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124508)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin